Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ShotCAR (MUC1)
- Development stage
- Preclinical
- Lead developer
- Hauul Bio
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
ShotCAR (MUC1) is a chimeric antigen receptor (CAR) T-cell therapy developed by Hauul Bio using its proprietary ShotCAR platform. The therapy targets Mucin 1 (MUC1), a transmembrane glycoprotein that is frequently overexpressed and aberrantly glycosylated in various solid tumors, including breast, lung, and colorectal cancers. By engineering a patient's T cells to express a CAR specific for MUC1, the therapy aims to induce a targeted immune response against malignant cells. The ShotCAR platform is specifically designed to enhance the efficacy and persistence of CAR-T cells within the immunosuppressive microenvironment typically associated with solid tumors.
- Other names
- ShotCAR MUC1Hauul Bio MUC1-CAR-T cell therapy
02
Targets
MUC1 (Mucin-1 Antigen)
Beyond the preview
Go deeper on ShotCAR (MUC1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ShotCAR (MUC1).